Abstract
Anal cancer is an uncommon malignancy. In addition to squamous cell carcinoma, there are a variety of other less common malignancies and benign pathologies that may afflict the anal canal, with which abdominal radiologists should be familiar. Abdominal radiologists should be familiar with the imaging features that can help distinguish different rare anal tumors beyond squamous cell carcinoma and that can aid in diagnosis therefore help steer management. This review discusses these uncommon pathologies with a focus on their imaging appearance, management, and prognosis.
Similar content being viewed by others
References
National Cancer Institute D, Surveillance Research Program. Cancer Stat Facts: Anal Cancer. https://seer.cancer.gov/statfacts/html/anus.html (2022). Accessed October 29, 2022.
Deshmukh AA, Suk R, Shiels MS, Sonawane K, Nyitray AG, Liu Y, et al. Recent Trends in Squamous Cell Carcinoma of the Anus Incidence and Mortality in the United States, 2001–2015. Journal of the National Cancer Institute. 2020;112(8):829–38. doi: https://doi.org/10.1093/jnci/djz219.
Shiels MS, Kreimer AR, Coghill AE, Darragh TM, Devesa SS. Anal Cancer Incidence in the United States, 1977–2011: Distinct Patterns by Histology and Behavior. Cancer Epidemiology, Biomarkers & Prevention: A Publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2015;24(10):1548–56. doi: https://doi.org/10.1158/1055-9965.Epi-15-0044.
Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, et al.: Global Cancer Observatory: Cancer Today. https://gco.iarc.fr/today (2020). Accessed November 11, 2022.
Li R, Shinde A, Fakih M, Sentovich S, Melstrom K, Nelson R, et al. Impact of Surgical Resection on Survival Outcomes After Chemoradiotherapy in Anal Adenocarcinoma. Journal of the National Comprehensive Cancer Network: JNCCN. 2019;17(10):1203–10. doi: https://doi.org/10.6004/jnccn.2019.7309.
American Cancer Society. Cancer Facts & Figures 2022. Atlanta: American Cancer Society; 2022.
Golia Pernicka JS, Sheedy SP, Ernst RD, Minsky BD, Ganeshan D, Rauch GM. MR staging of anal cancer: what the radiologist needs to know. Abdominal Radiology. 2019;44(11):3726–39. doi: https://doi.org/10.1007/s00261-019-02020-4.
Taliadoros V, Rafique H, Rasheed S, Tekkis P, Kontovounisios C. Management and Outcomes in Anal Canal Adenocarcinomas-A Systematic Review. Cancers. 2022;14(15). doi: https://doi.org/10.3390/cancers14153738.
Shi L, Zhang Y, Nie K, Sun X, Niu T, Yue N, et al. Machine learning for prediction of chemoradiation therapy response in rectal cancer using pre-treatment and mid-radiation multi-parametric MRI. Magnetic Resonance Imaging. 2019;61:33–40. doi: 0.1016/j.mri.2019.05.003.
Abel ME, Chiu YS, Russell TR, Volpe PA. Adenocarcinoma of the anal glands. Results of a survey. Diseases of the Colon and Rectum. 1993;36(4):383–7. doi: https://doi.org/10.1007/bf02053944.
Panés J, Rimola J. Perianal fistulizing Crohn's disease: pathogenesis, diagnosis and therapy. Nature Reviews Gastroenterology & Hepatology. 2017;14(11):652–64. doi: https://doi.org/10.1038/nrgastro.2017.104.
Sheedy SP, Bruining DH, Dozois EJ, Faubion WA, Fletcher JG. MR Imaging of Perianal Crohn Disease. Radiology. 2017;282(3):628–45. doi: https://doi.org/10.1148/radiol.2016151491.
Annese V, Beaugerie L, Egan L, Biancone L, Bolling C, Brandts C, et al. European Evidence-based Consensus: Inflammatory Bowel Disease and Malignancies. Journal of Crohn's & Colitis. 2015;9(11):945–65. doi: https://doi.org/10.1093/ecco-jcc/jjv141.
Kotsafti A, Scarpa M, Angriman I, Castagliuolo I, Caruso A. Fistula-Related Cancer in Crohn's Disease: A Systematic Review. Cancers. 2021;13(6). doi: https://doi.org/10.3390/cancers13061445.
Lad SV, Haider MA, Brown CJ, McLeod RS. MRI appearance of perianal carcinoma in Crohn's disease. J Magn Reson Imaging. 2007;26(6):1659–62. doi: https://doi.org/10.1002/jmri.21186.
Iesalnieks I, Gaertner WB, Glass H, Strauch U, Hipp M, Agha A, et al. Fistula-associated anal adenocarcinoma in Crohn's disease. Inflammatory Bowel Diseases. 2010;16(10):1643–8. doi: https://doi.org/10.1002/ibd.21228.
Thomas M, Bienkowski R, Vandermeer TJ, Trostle D, Cagir B. Malignant transformation in perianal fistulas of Crohn's disease: a systematic review of literature. Journal of Gastrointestinal Surgery: Official Journal of the Society for Surgery of the Alimentary Tract. 2010;14(1):66–73. doi: https://doi.org/10.1007/s11605-009-1061-x.
Palmieri C, Müller G, Kroesen AJ, Galata C, Rink AD, Morgenstern J, et al. Perianal Fistula-Associated Carcinoma in Crohn's Disease: A Multicentre Retrospective Case Control Study. Journal of Crohn's & Colitis. 2021;15(10):1686–93. doi: https://doi.org/10.1093/ecco-jcc/jjab057.
Hama Y, Makita K, Yamana T, Dodanuki K. Mucinous adenocarcinoma arising from fistula in ano: MRI findings. AJR American Journal of Roentgenology. 2006;187(2):517–21. doi: https://doi.org/10.2214/ajr.05.0011.
Díaz-Vico T, Fernández-Martínez D, García-Gutiérrez C, Suárez-Sánchez A, Cifrián-Canales I, Mendoza-Pacas GE, et al. Mucinous adenocarcinoma arising from chronic perianal fistula-a multidisciplinary approach. Journal of Gastrointestinal Oncology. 2019;10(3):589–96. doi: https://doi.org/10.21037/jgo.2019.01.11.
McLaughlin CC, Wu XC, Jemal A, Martin HJ, Roche LM, Chen VW. Incidence of noncutaneous melanomas in the U.S. Cancer. 2005;103(5):1000–7. doi: https://doi.org/10.1002/cncr.20866.
Kolosov A, Leskauskaite J, Dulskas A. Primary melanoma of the anorectal region: clinical and histopathological review of 17 cases. A retrospective cohort study. Colorectal Disease. 2021;23(10):2706–13. doi: https://doi.org/10.1111/codi.15816.
Wong VK, Lubner MG, Menias CO, Mellnick VM, Kennedy TA, Bhalla S, et al. Clinical and Imaging Features of Noncutaneous Melanoma. American Journal of Roentgenology. 2017;208(5):942–59. doi: https://doi.org/10.2214/ajr.16.16800.
Singer M, Mutch MG. Anal melanoma. Clin Colon Rectal Surg. 2006;19(2):78–87. doi: https://doi.org/10.1055/s-2006-942348.
Kelly P, Zagars GK, Cormier JN, Ross MI, Guadagnolo BA. Sphincter-sparing local excision and hypofractionated radiation therapy for anorectal melanoma: a 20-year experience. Cancer. 2011;117(20):4747–55. doi: https://doi.org/10.1002/cncr.26088.
Ross M. Patterns of Failure in Anorectal Melanoma. Archives of Surgery. 1990;125(3):313. doi: https://doi.org/10.1001/archsurg.1990.01410150035007.
Matsuoka H, Nakamura A, Iwamoto K, Sugiyama M, Hachiya J, Atomi Y, et al. Anorectal malignant melanoma: preoperative usefulness of magnetic resonance imaging. J Gastroenterol. 2005;40(8):836–42. doi: https://doi.org/10.1007/s00535-005-1638-4.
Jutten E, Kruijff S, Francken AB, Holzik MFL, van Leeuwen BL, van Westreenen HL, et al. Surgical treatment of anorectal melanoma: a systematic review and meta-analysis. BJS Open. 2021;5(6). doi: https://doi.org/10.1093/bjsopen/zrab107.
Bleicher J, Cohan JN, Huang LC, Peche W, Pickron TB, Scaife CL, et al. Trends in the management of anorectal melanoma: A multi-institutional retrospective study and review of the world literature. World Journal of Gastroenterology. 2021;27(3):267–80. doi: https://doi.org/10.3748/wjg.v27.i3.267.
National Comprehensive Cancer Network: NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®): Anal Carcinoma. https://www.nccn.org/professionals/physician_gls/pdf/anal.pdf (2017). Accessed October 29, 2022.
Sarode SC, Zarkar GA, Desai RS, Sabane VS, Kulkarni MA. Plasmablastic lymphoma of the oral cavity in an HIV-positive patient: a case report and review of literature. International Journal of Oral and Maxillofacial Surgery. 2009;38(9):993–9. doi: https://doi.org/10.1016/j.ijom.2009.03.720.
Carbone A, Vaccher E, Gloghini A. Hematologic cancers in individuals infected by HIV. Blood. 2022;139(7):995–1012. doi: https://doi.org/10.1182/blood.2020005469.
Teruya-Feldstein J, Chiao E, Filippa DA, Lin O, Comenzo R, Coleman M, et al. CD20-negative large-cell lymphoma with plasmablastic features: a clinically heterogenous spectrum in both HIV-positive and -negative patients. Annals of Oncology: Official Journal of the European Society for Medical Oncology. 2004;15(11):1673–9. doi: https://doi.org/10.1093/annonc/mdh399.
Castillo J, Pantanowitz L, Dezube BJ. HIV-associated plasmablastic lymphoma: lessons learned from 112 published cases. American Journal of Hematology. 2008;83(10):804–9. doi: https://doi.org/10.1002/ajh.21250.
Isfahani F, Amar S, Dave H, Gridley D. Plasmoblastic lymphoma as cause of perianal fistula: a case report and literature review. Journal of the International Association of Providers of AIDS Care. 2015;14(1):17–20. doi: https://doi.org/10.1177/2325957414553838.
Castillo JJ, Reagan JL. Plasmablastic lymphoma: a systematic review. The Scientific World Journal. 2011;11:687–96. doi: https://doi.org/10.1100/tsw.2011.59.
Nigri GR, Dente M, Valabrega S, Aurello P, D'Angelo F, Montrone G, et al. Gastrointestinal stromal tumor of the anal canal: an unusual presentation. World J Surg Oncol. 2007;5:20. doi: https://doi.org/10.1186/1477-7819-5-20.
Miettinen M, Furlong M, Sarlomo-Rikala M, Burke A, Sobin LH, Lasota J. Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the rectum and anus: a clinicopathologic, immunohistochemical, and molecular genetic study of 144 cases. The American Journal of Surgical Pathology. 2001;25(9):1121–33. doi: https://doi.org/10.1097/00000478-200109000-00002.
Parab TM, DeRogatis MJ, Boaz AM, Grasso SA, Issack PS, Duarte DA, et al. Gastrointestinal stromal tumors: a comprehensive review. Journal of Gastrointestinal Oncology. 2019;10(1):144–54. doi: https://doi.org/10.21037/jgo.2018.08.20.
Yu MH, Lee JM, Baek JH, Han JK, Choi BI. MRI features of gastrointestinal stromal tumors. AJR American Journal of Roentgenology. 2014;203(5):980–91. doi: https://doi.org/10.2214/ajr.13.11667.
Levy AD, Remotti HE, Thompson WM, Sobin LH, Miettinen M. Gastrointestinal stromal tumors: radiologic features with pathologic correlation. Radiographics. 2003;23(2):283–304, 456; quiz 532. doi: https://doi.org/10.1148/rg.232025146.
Duarte AL, Fouassier S, Herédia V. MR imaging features of anal gastrointestinal stromal tumor (GIST). Diagn Interv Imaging. 2017;98(6):513–4. doi: https://doi.org/10.1016/j.diii.2017.01.005.
Yang DY, Wang X, Yuan WJ, Chen ZH. Metastatic pattern and prognosis of gastrointestinal stromal tumor (GIST): a SEER-based analysis. Clin Transl Oncol. 2019;21(12):1654–62. doi: https://doi.org/10.1007/s12094-019-02094-y.
Amin MB ES, Greene F, Byrd DR, Brookland RK, Washington MK, Gershenwald JE, Compton CC, Hess KR, et al. (Eds.). AJCC Cancer Staging Manual (8th edition). Springer: American Joint Commission on Cancer. 2017.
Azzaza M, Ammar H, Abdessayed N, Gupta R, Nakhli MS, Chhaider A, et al. Wide local excision for anal GIST: A case report and review of literature. Int J Surg Case Rep. 2017;30:97–100. doi: https://doi.org/10.1016/j.ijscr.2016.11.046.
Kusminsky RE, Bailey W. Leiomyomas of the rectum and anal canal: report of six cases and review of the literature. Diseases of the Colon and Rectum. 1977;20(7):580–99. doi: https://doi.org/10.1007/bf02586622.
Walsh TH, Mann CV. Smooth muscle neoplasms of the rectum and anal canal. The British Journal of Surgery. 1984;71(8):597–9. doi: https://doi.org/10.1002/bjs.1800710810.
Szklaruk J, Tamm EP, Choi H, Varavithya V. MR imaging of common and uncommon large pelvic masses. Radiographics. 2003;23(2):403–24. doi: https://doi.org/10.1148/rg.232025089.
Walker EA, Salesky JS, Fenton ME, Murphey MD. Magnetic resonance imaging of malignant soft tissue neoplasms in the adult. Radiologic Clinics of North America. 2011;49(6):1219–34, vi. doi: https://doi.org/10.1016/j.rcl.2011.07.006.
Song JY, Kim SY, Park EG, Kim CJ, Kim DG, Lee HK, et al. Schwannoma in the retroperitoneum. Journal of Obstetrics and Gynaecology Research. 2007;33(3):371–5.
Sordillo PP, Helson L, Hajdu SI, Magill GB, Kosloff C, Golbey RB, et al. Malignant schwannoma—clinical characteristics, survival, and response to therapy. Cancer. 1981;47(10):2503–9.
Pan J, Jing H, Tian X, Fan Z. Schwannoma with an uncommon anal location. Oncol Lett. 2014;8(5):1945–6. doi: https://doi.org/10.3892/ol.2014.2459.
Labędź W, Kubaszewski L, Adamek J. Operative treatment of Schwannoma, the primary sacral tumor--case presentation. Pol Orthop Traumatol. 2012;77:10–6.
Huang M, Qian H, Wang J, Zhao Q. Giant presacral schwannoma in man: report of a case with emphasis on imaging findings. World Neurosurgery. 2020;133:14–6.
Beaman FD, Kransdorf MJ, Menke DM. Schwannoma: radiologic–pathologic correlation. Radiographics. 2004;24(5):1477–81.
Hughes MJ, Thomas JM, Fisher C, Moskovic EC. Imaging features of retroperitoneal and pelvic schwannomas. Clin Radiol. 2005;60(8):886–93. doi: https://doi.org/10.1016/j.crad.2005.01.016.
Hayasaka K, Tanaka Y, Soeda S, Huppert P, Claussen C. MR findings in primary retroperitoneal schwannoma. Acta Radiologica. 1999;40(1):78–82.
Hoarau N, Slim K, Da Ines D. CT and MR imaging of retroperitoneal schwannoma. Diagnostic and Interventional Imaging. 2013;94(11):1133–9.
Albert P, Patel J, Badawy K, Weissinger W, Brenner M, Bourhill I, et al. Peripheral nerve schwannoma: a review of varying clinical presentations and imaging findings. The Journal of Foot and Ankle Surgery. 2017;56(3):632–7.
Ke Z, Yi M, Li J, Hai HR, Yan L, Rong H, et al. The management of retroperitoneal giant schwannomas in AIDS patients: A case report. Oncol Lett. 2013;5(4):1430–2. doi: https://doi.org/10.3892/ol.2013.1191.
Sutton BJ, Laudadio J. Aggressive angiomyxoma. Archives of Pathology & Laboratory Medicine. 2012;136(2):217–21. doi: https://doi.org/10.5858/arpa.2011-0056-RS.
Surabhi VR, Garg N, Frumovitz M, Bhosale P, Prasad SR, Meis JM. Aggressive angiomyxomas: a comprehensive imaging review with clinical and histopathologic correlation. AJR American Journal of Roentgenology. 2014;202(6):1171–8. doi: https://doi.org/10.2214/ajr.13.11668.
Fetsch JF, Laskin WB, Lefkowitz M, Kindblom LG, Meis-Kindblom JM. Aggressive angiomyxoma: a clinicopathologic study of 29 female patients. Cancer. 1996;78(1):79–90. doi: https://doi.org/10.1002/(sici)1097-0142(19960701)78:1<79::Aid-cncr13>3.0.Co;2-4.
Grce M, Husnjak K, Skerlev M, Lipozencić J, Pavelić K. Detection and typing of human papillomaviruses by means of polymerase chain reaction and fragment length polymorphism in male genital lesions. Anticancer Research. 2000;20(3b):2097–102.
Longacre TA, Kong CS, Welton ML. Diagnostic problems in anal pathology. Advances in Anatomic Pathology. 2008;15(5):263–78. doi: https://doi.org/10.1097/PAP.0b013e318183234b.
Papiu HS, Dumnici A, Olariu T, Onita M, Hornung E, Goldis D, et al. Perianal giant condyloma acuminatum (Buschke–Löwenstein tumor). Case report and review of the literature. Chirurgia (Bucharest, Romania: 1990). 2011;106(4):535–9.
Wroński K, Bocian R. Surgical excision of extensive anal condylomata is a safe operation without risk of anal stenosis. Postepy higieny i medycyny doswiadczalnej (Online). 2012;66:153–7. doi: https://doi.org/10.5604/17322693.987538.
Fazendin EA, Crean AJ, Fazendin JM, Kucejko RJ, Gill HS, Poggio JL, et al. Condyloma Acuminatum, Anal Intraepithelial Neoplasia, and Anal Cancer in the Setting of HIV: Do We Really Understand the Risk? Diseases of the Colon and Rectum. 2017;60(10):1078–82. doi: https://doi.org/10.1097/dcr.0000000000000890.
Asel M, LeBoeuf NR. Extramammary Paget's Disease. Hematol Oncol Clin North Am. 2019;33(1):73–85. doi: https://doi.org/10.1016/j.hoc.2018.09.003.
Surabhi VR, Menias CO, Amer AM, Elshikh M, Katabathina VS, Hara AK, et al. Tumors and Tumorlike Conditions of the Anal Canal and Perianal Region: MR Imaging Findings. Radiographics: a review publication of the Radiological Society of North America, Inc. 2016;36(5):1339–53. doi: https://doi.org/10.1148/rg.2016150209.
Perez DR, Trakarnsanga A, Shia J, Nash GM, Temple LK, Paty PB, et al. Management and outcome of perianal Paget's disease: a 6-decade institutional experience. Diseases of the Colon and Rectum. 2014;57(6):747–51. doi: https://doi.org/10.1097/dcr.0000000000000100.
Bulur I, Boyuk E, Saracoglu ZN, Arik D. Perianal Basal cell carcinoma. Case Reports in Dermatology. 2015;7(1):25–8. doi: https://doi.org/10.1159/000380847.
Funding
This work was partially supported by the National Institutes of Health/National Cancer Institute P30 Cancer Center support grant (P30 CA008748).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript.
Ethical approval
No ethical approval was needed for this review.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
El Homsi, M., Golia Pernicka, J.S., Lall, C. et al. Beyond squamous cell carcinoma: MRI appearance of uncommon anal neoplasms and mimickers. Abdom Radiol 48, 2898–2912 (2023). https://doi.org/10.1007/s00261-023-03891-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00261-023-03891-4